Jonathan O'Keeffe is a highly educated and experienced individual who has made significant contributions to the field of precision neuro-therapeutics. He is currently the CEO at Machine Medicine, a platform service that facilitates the design, development, and clinical deployment of such therapeutics. Jonathan holds several degrees, including a BA in Medical Sciences, BM BCh in Physiology and Medicine, a PhD in Computational Neuroscience, and an MSc in Machine Learning. Furthermore, he studied a graduate certificate in theoretical statistics and probability at The Open University, and a BA in Philosophy at the University of York.

Jonathan previously served as an Advisory Board Member at MindBerry Group and worked as an Academic Clinical Fellow in Neurology at UCL. He also served as a Wellcome Trust Clinical Fellow at the University of Cambridge and worked as a Dr at NHS.

Machine Medicine's first product, Kelvin-PD, is an intelligent, smart data-capture, integration, and analysis tool for Parkinson's disease and neuromodulation. Jonathan's expertise in computational neuroscience and machine learning has been critical in developing this product.

Overall, Jonathan O'Keeffe's background is impressive and diverse, making him an expert in multiple areas of medicine, mathematics, and data analytics. He continues to drive innovation in the field of neuro-therapeutics and is an asset to the healthcare industry.